InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: entdoc post# 73486

Monday, 01/02/2012 1:05:12 PM

Monday, January 02, 2012 1:05:12 PM

Post# of 346281
Entdoc, like you I look forward to the future when bavi is paired with something else.
I am thinking the Bavi-IL2 immunocytokine as in the Vaccine paper from 2011:
Enhancing the potency of a whole-cell breast cancer vaccine in mice with an
antibody-IL-2 immunocytokine that targets exposed phosphatidylserine

by Xianming Huang,DanYe,PhilipE.Thorpe

I think this second-generation could be much more efficacious. Maybe Bavi-IL12,
or Bavi-IFN-gamma. The plan is obviously to get bavi with chemo approved and
generating money to pay for more research and trials of bavi combined and used
in other ways. There is much, much more potential than just bavi alone. Don't forget
the other antibodies either, i.e. PGN632.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News